BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 16243008)

  • 1. Voriconazole therapy in children with cystic fibrosis.
    Hilliard T; Edwards S; Buchdahl R; Francis J; Rosenthal M; Balfour-Lynn I; Bush A; Davies J
    J Cyst Fibros; 2005 Dec; 4(4):215-20. PubMed ID: 16243008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To treat or not to treat with antifungal agents?
    Schoeni MH
    J Cyst Fibros; 2005 Dec; 4(4):213-4. PubMed ID: 16253572
    [No Abstract]   [Full Text] [Related]  

  • 4. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual case of pulmonary invasive aspergillosis and aspergilloma cured with voriconazole in a patient with cystic fibrosis.
    Chow L; Brown NE; Kunimoto D
    Clin Infect Dis; 2002 Nov; 35(9):e106-10. PubMed ID: 12384856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis.
    Jain LR; Denning DW
    J Infect; 2006 May; 52(5):e133-7. PubMed ID: 16427702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Glackin L; Leen G; Elnazir B; Greally P
    Ir Med J; 2009 Jan; 102(1):29. PubMed ID: 19284017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole inhibition of vitamin A metabolism: are adverse events increased in cystic fibrosis patients?
    Cheng MP; Paquette K; Lands LC; Ovetchkine P; Théoret Y; Quach C
    Pediatr Pulmonol; 2010 Jul; 45(7):661-6. PubMed ID: 20575095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of voriconazole therapy in 2 patients with pulmonary fungus balls.
    Gutierrez F; Masia M; Ramos JM; Elia M; Rodriguez-Tudela JL; Cuenca-Estrella M
    Clin Infect Dis; 2005 Jun; 40(11):1706-7. PubMed ID: 15889381
    [No Abstract]   [Full Text] [Related]  

  • 11. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspergillus/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity.
    Chotirmall SH; Branagan P; Gunaratnam C; McElvaney NG
    Respir Care; 2008 Aug; 53(8):1035-41. PubMed ID: 18655741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
    Beernaert LA; Pasmans F; Baert K; Van Waeyenberghe L; Chiers K; Haesebrouck F; Martel A
    Vet Microbiol; 2009 Nov; 139(3-4):393-7. PubMed ID: 19574001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases.
    Mouas H; Lutsar I; Dupont B; Fain O; Herbrecht R; Lescure FX; Lortholary O;
    Clin Infect Dis; 2005 Apr; 40(8):1141-7. PubMed ID: 15791514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of pulmonary Wangiella dermatitidis infection with oral voriconazole.
    Bulloch MN
    J Clin Pharm Ther; 2011 Jun; 36(3):433-6. PubMed ID: 21062332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia.
    Przepiorka D; Buadi FK; McClune B
    Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole-induced retinoid-like photosensitivity in children.
    Rubenstein M; Levy ML; Metry D
    Pediatr Dermatol; 2004; 21(6):675-8. PubMed ID: 15575856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of voriconazole-related phototoxicity in cystic fibrosis patients.
    Rondeau S; Couderc L; Dominique S; Pramil S; Leguillon C; Masseline B; Favennec L; Marguet C
    Eur Respir J; 2012 Mar; 39(3):782-4. PubMed ID: 22379155
    [No Abstract]   [Full Text] [Related]  

  • 19. Voriconazole treatment for less-common, emerging, or refractory fungal infections.
    Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E
    Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole pharmacokinetics and photosensitivity in children with cystic fibrosis.
    Markantonis SL; Katelari A; Pappa E; Doudounakis S
    J Cyst Fibros; 2012 May; 11(3):246-52. PubMed ID: 22284963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.